RedHill Biopharma Ltd - Company Profile
Powered by
All the data and insights you need on RedHill Biopharma Ltd in one report.
- Save hours of research time and resources with
our up-to-date RedHill Biopharma Ltd Strategy Report
- Understand RedHill Biopharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutin omeprazole; naloxegol; and rifamycin. RedHill is investigating its pipeline candidates for the treatment of Crohn's disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer and novel coronavirus disease (COVID-19). The company has a subsidiary in the US. RedHill is headquartered in Tel Aviv, Israel.
RedHill Biopharma Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Prescription Drugs: | Talicia |
A combination of Omeprazole, Amoxicillin and Rifabutin | Movantik |
Naloxegol | Aemcolo |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | RedHill Biopharma Ltd | Hayat Pharmaceutical Industries | BioLineRx Ltd | SciSparc Ltd | Notable Labs Ltd |
---|---|---|---|---|---|
Headquarters | Israel | Jordan | Israel | Israel | United States of America |
City | Tel Aviv-Yafo | Amman | Modiin | Tel Aviv-Yafo | Foster City |
State/Province | - | - | - | - | California |
No. of Employees | 53 | 191 | 79 | 3 | 7 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Dror Ben-Asher | Chairman; Chief Executive Officer | Executive Board | 2011 | 57 |
Rick D. Scruggs | Director; Chief Commercial Officer | Executive Board | 2020 | 63 |
Razi Ingber | Chief Financial Officer | Senior Management | 2023 | 39 |
Gilead Raday | Chief Operating Officer | Senior Management | 2016 | 48 |
Kristin Comer | Chief Compliance Officer; Vice President; General Counsel | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward